Abstract: Fatty acid-based, pre-cure-derived biomaterials, methods of making the biomaterials, and methods of using them as drug delivery carriers are described. The fatty acid-derived biomaterials can be utilized alone or in combination with a medical device for the release and local delivery of one or more therapeutic agents. Methods of forming and tailoring the properties of said biomaterials and methods of using said biomaterials for treating injury in a mammal are also provided.

Abstract: Fatty acid-based, pre-cure-derived biomaterials, methods of making the biomaterials, and methods of using them as drug delivery carriers are described. The fatty acid-derived biomaterials can be utilized alone or in combination with a medical device for the release and local delivery of one or more therapeutic agents. Methods of forming and tailoring the properties of said biomaterials and methods of using said biomaterials for treating injury in a mammal are also provided.

Abstract: Fatty acid-based, pre-cure-derived biomaterials, methods of making the biomaterials, and methods of using them as drug delivery carriers are described. The fatty acid-derived biomaterials can be utilized alone or in combination with a medical device for the release and local delivery of one or more therapeutic agents. Methods of forming and tailoring the properties of said biomaterials and methods of using said biomaterials for treating injury in a mammal are also provided.

Abstract: A deployment device for a flexible implant includes a housing and one or two chambers formed therein. When two chambers are included, the housing can have two elongate openings formed in its outer sides, each providing side access to one of the chambers, and the flexible implant can be rolled into a double-rolled configuration and placed in the chambers of the deployment device in such a way that a middle portion of the flexible implant is external to the housing. When the flexible implant is rolled and loaded in the deployment device, the flexible implant can extend out through open end(s) of the chamber(s) or can be encapsulated within the chamber(s). The flexible implant can be provided separate from the deployment device. The flexible implant can include a flexible base sheet including a body portion and a tab. A flexible separable layer can be removably disposed on the body portion.

Abstract: A deployment device for a flexible implant includes a housing and one or two chambers formed therein. When two chambers are included, the housing can have two elongate openings formed in its outer sides, each providing side access to one of the chambers, and the flexible implant can be rolled into a double-rolled configuration and placed in the chambers of the deployment device in such a way that a middle portion of the flexible implant is external to the housing. When the flexible implant is rolled and loaded in the deployment device, the flexible implant can extend out through open end(s) of the chamber(s) or can be encapsulated within the chamber(s). The flexible implant can be provided separate from the deployment device. The flexible implant can include a flexible base sheet including a body portion and a tab. A flexible separable layer can be removably disposed on the body portion.

Abstract: Fatty acid-based, pre-cure-derived biomaterials, methods of making the biomaterials, and methods of using them as drug delivery carriers are described. The fatty acid-derived biomaterials can be utilized alone or in combination with a medical device for the release and local delivery of one or more therapeutic agents. Methods of forming and tailoring the properties of said biomaterials and methods of using said biomaterials for treating injury in a mammal are also provided.

Abstract: Fatty acid-derived biomaterials, methods of making the biomaterials, and methods of using them as drug delivery carriers are described. The fatty acid-derived biomaterials can be utilized alone or in combination with a medical device for the release and local delivery of one or more therapeutic agents. Methods of forming and tailoring the properties of said biomaterials and methods of using said biomaterials for treating injury in a mammal are also provided.

Abstract: Fatty acid-based, pre-cure-derived biomaterials, methods of making the biomaterials, and methods of using them as drug delivery carriers are described. The fatty acid-derived biomaterials can be utilized alone or in combination with a medical device for the release and local delivery of one or more therapeutic agents. Methods of forming and tailoring the properties of said biomaterials and methods of using said biomaterials for treating injury in a mammal are also provided.

Abstract: Fatty acid-derived biomaterials, methods of making the biomaterials, and methods of using them as drug delivery carriers are described. The fatty acid-derived biomaterials can be utilized alone or in combination with a medical device for the release and local delivery of one or more therapeutic agents. Methods of forming and tailoring the properties of said biomaterials and methods of using said biomaterials for treating injury in a mammal are also provided.

Abstract: Fatty acid-based, pre-cure-derived biomaterials, methods of making the biomaterials, and methods of using them as drug delivery carriers are described. The fatty acid-derived biomaterials can be utilized alone or in combination with a medical device for the release and local delivery of one or more therapeutic agents. Methods of forming and tailoring the properties of said biomaterials and methods of using said biomaterials for treating injury in a mammal are also provided.

Abstract: Fatty acid-derived biomaterials, methods of making the biomaterials, and methods of using them as drug delivery carriers are described. The fatty acid-derived biomaterials can be utilized alone or in combination with a medical device for the release and local delivery of one or more therapeutic agents. Methods of forming and tailoring the properties of said biomaterials and methods of using said biomaterials for treating injury in a mammal are also provided.

Abstract: Fatty acid-based, pre-cure-derived biomaterials, methods of making the biomaterials, and methods of using them as drug delivery carriers are described. The fatty acid-derived biomaterials can be utilized alone or in combination with a medical device for the release and local delivery of one or more therapeutic agents. Methods of forming and tailoring the properties of said biomaterials and methods of using said biomaterials for treating injury in a mammal are also provided.

Abstract: A deployment device for a flexible implant includes a housing and one or two chambers formed therein. When two chambers are included, the housing can have two elongate openings formed in its outer sides, each providing side access to one of the chambers, and the flexible implant can be rolled into a double-rolled configuration and placed in the chambers of the deployment device in such a way that a middle portion of the flexible implant is external to the housing. When the flexible implant is rolled and loaded in the deployment device, the flexible implant can extend out through open end(s) of the chamber(s) or can be encapsulated within the chamber(s). The flexible implant can be provided separate from the deployment device. The flexible implant can include a flexible base sheet including a body portion and a tab. A flexible separable layer can be removably disposed on the body portion.

Abstract: A method, a kit, and an apparatus provide a coating on an implantable medical device. The apparatus includes housing, a sealed reservoir chamber disposed in the housing, a reducing template, and a reservoir access port. The sealed reservoir contains the coating material. The reducing template is sized to receive a medical device therethrough for application of the coating material. A seal breaching mechanism can be provided and adapted to breach the sealed reservoir upon activation of the apparatus. The reservoir access port, which is disposed in the housing, is adapted to fluidly couple the reducing template with the reservoir chamber upon activation of the apparatus for coating the medical device.

Abstract: The present invention related to substantially-thickened therapeutic formulation comprising an oil-based composition and a therapeutic agent, wherein the therapeutic agent is of a reduced particle size.

Abstract: An apparatus is provided for indicating the presence of pressure within a collection chamber of a device such as a chest drainage device. The apparatus includes a bladder configured to be positioned within the collection chamber or within another chamber in fluid flow communication with the collection chamber. The bladder has a concavity formed therein and configured to contract or expand in response to pressure in the collection chamber. The apparatus also includes surfaces associated with the bladder that are configured to move with respect to one another upon contraction or expansion of the concavity of the bladder, thereby indicating pressure within the collection chamber.

Abstract: Fatty acid-based, pre-cure-derived biomaterials, methods of making the biomaterials, and methods of using them as drug delivery carriers are described. The fatty acid-derived biomaterials can be utilized alone or in combination with a medical device for the release and local delivery of one or more therapeutic agents. Methods of forming and tailoring the properties of said biomaterials and methods of using said biomaterials for treating injury in a mammal are also provided.

Abstract: Fatty acid-derived biomaterials, methods of making the biomaterials, and methods of using them as drug delivery carriers are described. The fatty acid-derived biomaterials can be utilized alone or in combination with a medical device for the release and local delivery of one or more therapeutic agents. Methods of forming and tailoring the properties of said biomaterials and methods of using said biomaterials for treating injury in a mammal are also provided.

Abstract: A method, a kit, and an apparatus provide a coating on an implantable medical device. The apparatus includes housing, a sealed reservoir chamber disposed in the housing, a reducing template, and a reservoir access port. The sealed reservoir contains the coating material. The reducing template is sized to receive a medical device therethrough for application of the coating material. A seal breaching mechanism can be provided and adapted to breach the sealed reservoir upon activation of the apparatus. The reservoir access port, which is disposed in the housing, is adapted to fluidly couple the reducing template with the reservoir chamber upon activation of the apparatus for coating the medical device.

Abstract: An apparatus and a method for applying a coating to a medical device such as a stent, balloon, or catheter, shortly before insertion or implantation are described. The apparatus and method produce uniform consistent coverage of the medical device in a predictable, repeatable and controllable manner and reduce the need for preservative components in the coating or for excessive curing or hardening of the coating.